Navigation Links
Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
Date:8/22/2007

for its lower content of certain

immunoglobulins called IgA, for certain patients experiencing adverse

reactions from other IGIV therapies.

-- GAMMAGARD LIQUID and GAMMAGARD S/D Portability - Launched in late 2006,

this program is designed to provide hospitals with continued access to

GAMMAGARD irrespective of changes to their group purchasing

organization affiliation.

Patient organizations welcomed the announcement of Baxter's newest patient access innovation. "Access to the IGIV product prescribed by their physician is extremely important for PI patients," said Marcia Boyle, founder and president of the Immune Deficiency Foundation, a national nonprofit patient organization dedicated to improving the diagnosis and treatment of primary immunodeficiency diseases through research, education and advocacy. "Baxter's program will be extremely helpful to PI patients by reassuring that they will not have to change from their product of choice." Noting the success of Baxter's other patient centric initiatives, Ms. Boyle added, "We would love to see such a program developed for all of the patients in our community who use GAMMAGARD LIQUID and GAMMAGARD S/D."

"Baxter has been a pioneer in advancing the science of IGIV, and its intent to establish a program that maintains continuity in IGIV therapy at the patient level is an important innovation in the industry -- one that is sure to be embraced by PID patients who use GAMMAGARD LIQUID and GAMMAGARD S/D," added Fred Modell, co-founder of the Jeffrey Modell Foundation, a national nonprofit organization dedicated to early and precise diagnosis, meaningful treatment and ultimately cures of PID.

Baxter's GARDian Program

Baxter plans to launch a pilot of GARDian in early 2008. The pilot initiative and the ensuing program will be open to current patients in the United States that routinely use the product as prescribed by a physician. Using a simple, volunt
'/>"/>

SOURCE Baxter International Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Merge launches diagnostic mammography workstation in Europe
2. Einstein Wireless launches cellular alert system
3. Logistics Health launches compliance management tool
4. UW-Madison launches new high-speed research network
5. UWM launches research foundation
6. Weather information companies launch data product
7. TeraMedica launches information manager
8. GE Healthcare launches hybrid electronic record
9. Cedara launches new version of DICOM toolkit
10. Merge launches Spanish version of imaging tool
11. Orbitec will use $25 million Air Force contract to make small launch vehicle
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2009)... ON, Dec. 10 /PRNewswire-FirstCall/ - YM BioSciences Inc. ... life sciences product development company that identifies and ... at various stages of development, today provided an ... in the merger of Cytopia Ltd. into YM, ... 2009. The board of directors of Cytopia has ...
(Date:12/10/2009)... 10 Vivakor, Inc. (OTC Bulletin ... entered into an exclusive, $5 million license ... Inc. ( www.regeneca.com ). The agreement ... a new cutting-edge nutraceutical formulation developed by ... future formulations by Vivakor for Regeneca. Under ...
(Date:12/10/2009)... Biosciences Corporation (NASDAQ: MATK) announced today that it has ... dairy company Fonterra Co-operative Group Limited for the use of ... products for pregnant and nursing mothers. , ... ... Martek Biosciences Corporation (NASDAQ: MATK) announced today that it ...
(Date:12/10/2009)... -- Northwest Biotherapeutics, Inc. ("NWBT" or the "Company") (OTC ... has joined the company,s Board of Directors. Mr. ... School, currently serves on six other corporate boards. ... of four presidential campaigns, including those of John Kerry, ... those roles, he led fundraising of over $800 million. ...
Breaking Biology Technology:YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 4Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 3Martek Signs Sole-Source Supply Agreement with Fonterra 2Martek Signs Sole-Source Supply Agreement with Fonterra 3Northwest Biotherapeutics Announces Appointment of Robert A. Farmer to the Board of Directors 2Northwest Biotherapeutics Announces Appointment of Robert A. Farmer to the Board of Directors 3
... ST. LOUIS, Sept. 12 Prolog Ventures, a ... announced that Dan,Broderick has joined the firm as ... of experience in early-stage investing, venture fund,management, and ... was a managing director at Mason,Wells in Milwaukee, ...
... HOST CONFERENCE CALL AT 10:00AM EDT, EDMONTON, ... BIOM ) (TSX: BRA) (the "Company") today ... a proposal to change its,jurisdiction of incorporation from ... Delaware in the United States of America through ...
... Sept. 12 Genstruct Inc., a,biotechnology company translating ... therapeutics, announced today that its president and,CEO, Dr. ... at the Oncology,Clinical Trial Summit in Arlington, Va., ... a panel discussion focused on,"Enhancing Development and Commercial ...
Other Biology Technology:Dan Broderick Joins Prolog Ventures as Partner 2Dan Broderick Joins Prolog Ventures as Partner 3Biomira Announces Plan to Reincorporate in the United States 2Biomira Announces Plan to Reincorporate in the United States 3Biomira Announces Plan to Reincorporate in the United States 4Biomira Announces Plan to Reincorporate in the United States 5Biomira Announces Plan to Reincorporate in the United States 6Genstruct CEO, Dr. Keith Elliston, Invited to Speak at Oncology Clinical Trial Summit 2
(Date:12/14/2009)... -- MODA Technology Partners, a global software company ... testing for the Pharmaceutical industry, today announced the ... generation mobile data acquisition platform. The latest release ... their regulated manufacturing processes. ,, MODA 3.0 ... Fully-Configurable Test Methods: Each test method in ...
(Date:12/13/2009)... have discovered five genetic variants that are associated with ... an international consortium of 96 scientists from 63 centres ... molecular basis of lung diseases. , The new findings ... Chronic Obstructive Pulmonary Disease (COPD) and asthma. In the ... because the molecular pathways that affect the health of ...
(Date:12/11/2009)... understand that green plants photosynthesize, absorb carbon dioxide ... global-scale effects that photosynthesis has had on Earth. ... origins and evolution of photosynthesis is Jeffrey Touchman, ... Life Sciences. , Oxygen, one of the by-products ... their descendants (including algae and higher plants), transformed ...
Breaking Biology News(10 mins):MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2New genes for lung disease discovered 2'Extreme' genes shed light on origins of photosynthesis 2'Extreme' genes shed light on origins of photosynthesis 3Want to attract the opposite sex 3F Its in the Smile 51639 1Want to attract the opposite sex 3F Its in the Smile 51639 2Nick Jonas Opens Up About His Diabetes In Exclusive TV Interview July 19th 2009 on dLife 51637 1Nick Jonas Opens Up About His Diabetes In Exclusive TV Interview July 19th 2009 on dLife 51637 2Encompass Group to Offer the Liftaem 28TM 29 Lateral Patient Transfer System 51635 1Encompass Group to Offer the Liftaem 28TM 29 Lateral Patient Transfer System 51635 2
... Michigan's,Comprehensive Cancer Center and the National Cancer Institute ... of skin cancer.,Andrzej Dlugosz, M.D., a professor of ... the University of Michigan and the National,Cancer Institute ... in basal cell carcinoma ?the most common form ...
... researchers at UT Southwestern Medical Center challenge one of ... one another. , Every time we move, feel emotions, ... our body transmit messages to one another via chemical ... synaptic vesicles that sequester neurotransmitters and release them when ...
... How nature wraps and tags genes determines if and when ... Massachusetts Institute of Technology (M.I.T.). They did the largest, most ... the human genome. , Their findings reveal surprising and previously ... of the human body and in diseases such as cancer. ...
Other Biology News:U-M scientists find genes that control growth of common skin cancer 2U-M scientists find genes that control growth of common skin cancer 3New research questions basic tenet of neuron function 2Protein Packages Found To Activate Genes; May Be What Regulates Development And Disease 2Protein Packages Found To Activate Genes; May Be What Regulates Development And Disease 3
... Strain Competent Cell Sets Sets of ... combinations The most common method ... coli is to use chemically competent ... in the laboratory, greater efficiency, reproducibility and ...
... The BD Pathway Bioimager is an automated, ... imaging system that has been integrated into ... Pathway was designed to provide high-resolution, automated ... assist in developing better cell-based assays. The ...
... Imager delivers high resolution CCD confocal imaging ... effective optical package that fits on your ... combined with high quantum efficiency CCD cameras, ... recording at up to 100 fps. A ...
... Methylation Kit uses a simplified procedure and ... analysis. The kit is based on the ... cytosine and sodium bisulfite where cytosine is ... Kits innovative in-column desulphonation reaction eliminates several ...
Biology Products: